Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.

Connolly BA, O'Connell DP, Lamon-Fava S, LeBlanc DF, Kuang YL, Schaefer EJ, Coppage AL, Benedict CR, Kiritsy CP, Bachovchin WW.

Metabolism. 2013 Dec;62(12):1840-9. doi: 10.1016/j.metabol.2013.08.001. Epub 2013 Sep 13.

PMID:
24035454
2.

Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.

Watanabe T, Takahashi K, Kanome T, Hongo S, Miyazaki A, Koba S, Katagiri T, Pakara R, Benedict CR.

Hypertens Res. 2006 Oct;29(10):821-31.

PMID:
17283870
3.

The peroxidative coupling of hemigossypol to (+)- and (-)-gossypol in cottonseed extracts.

Benedict CR, Liu J, Stipanovic RD.

Phytochemistry. 2006 Feb;67(4):356-61. Epub 2006 Jan 5.

PMID:
16403543
4.

Terpenoid aldehyde formation and lysigenous gland storage sites in cotton: variant with mature glands but suppressed levels of terpenoid aldehydes.

Benedict CR, Martin GS, Liu J, Puckhaber L, Magill CW.

Phytochemistry. 2004 May;65(10):1351-9.

PMID:
15231408
5.

Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes.

Pakala R, Watanabe T, Benedict CR.

Cardiovasc Radiat Med. 2002 Apr-Jun;3(2):95-101.

PMID:
12699839
6.

Reduced levels of cadinane sesquiterpenoids in cotton plants expressing antisense (+)-delta-cadinene synthase.

Martin GS, Liu J, Benedict CR, Stipanovic RD, Magill CW.

Phytochemistry. 2003 Jan;62(1):31-8.

PMID:
12475616
7.

Lysophosphatidylcholine potentiates the mitogenic effect of various vasoactive compounds on rabbit aortic smooth muscle cells.

Watanabe T, Koba S, Katagiri T, Pakala R, Benedict CR.

Jpn Heart J. 2002 Jul;43(4):409-16.

8.
9.
10.

Cloning and expression of desoxyhemigossypol-6-O-methyltransferase from cotton (Gossypium barbadense).

Liu J, Benedict CR, Stipanovic RD, Magill CW, Bell AA.

J Agric Food Chem. 2002 May 22;50(11):3165-72.

PMID:
12009981
11.
12.

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.

Tang WH, Vagelos RH, Yee YG, Benedict CR, Willson K, Liss CL, Fowler MB.

J Am Coll Cardiol. 2002 Jan 2;39(1):70-8. Erratum in: J Am Coll Cardiol 2002 Feb 20;39(4):746.

13.

Serotonin potentiates angiotensin II--induced vascular smooth muscle cell proliferation.

Watanabe T, Pakala R, Katagiri T, Benedict CR.

Atherosclerosis. 2001 Dec;159(2):269-79.

PMID:
11730806
14.

Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation.

Watanabe T, Pakala R, Katagiri T, Benedict CR.

J Hypertens. 2001 Dec;19(12):2191-6.

PMID:
11725163
15.

Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.

Watanabe T, Pakala R, Katagiri T, Benedict CR.

J Vasc Res. 2001 Jul-Aug;38(4):341-9.

PMID:
11455205
16.

Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells.

Watanabe T, Pakala R, Katagiri T, Benedict CR.

Circulation. 2001 Jul 3;104(1):16-8.

PMID:
11435331
17.
19.

Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation.

Watanabe T, Pakala R, Katagiri T, Benedict CR.

J Hypertens. 2001 Apr;19(4):731-9.

PMID:
11330876
20.

The cyclization of farnesyl diphosphate and nerolidyl diphosphate by a purified recombinant delta-cadinene synthase.

Benedict CR, Lu JL, Pettigrew DW, Liu J, Stipanovic RD, Williams HJ.

Plant Physiol. 2001 Apr;125(4):1754-65.

21.
22.
23.

Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.

Koba S, Pakala R, Watanabe T, Katagiri T, Benedict CR.

Prostaglandins Leukot Essent Fatty Acids. 2000 Dec;63(6):329-35.

PMID:
11133169
24.
25.

Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor.

Pakala R, Liang CT, Benedict CR.

Thromb Res. 2000 Oct 1;100(1):89-96.

PMID:
11053621
26.

Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.

Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D.

J Pharmacol Exp Ther. 2000 Nov;295(2):614-20.

PMID:
11046096
27.

Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.

Sabbah HN, Stanley WC, Sharov VG, Mishima T, Tanimura M, Benedict CR, Hegde S, Goldstein S.

Circulation. 2000 Oct 17;102(16):1990-5.

PMID:
11034950
28.
31.

RAR gamma agonists inhibit proliferation of vascular smooth muscle cells.

Pakala R, Benedict CR.

J Cardiovasc Pharmacol. 2000 Feb;35(2):302-8.

PMID:
10672865
32.

Modulation of endothelial cell proliferation by retinoid x receptor agonists.

Pakala R, Benedict CR.

Eur J Pharmacol. 1999 Dec 3;385(2-3):255-61.

PMID:
10607884
33.

Beta(2)-glycoprotein I promotes the binding of anionic phospholipid vesicles by macrophages.

Thiagarajan P, Le A, Benedict CR.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2807-11.

PMID:
10559030
35.

Vascular smooth muscle proliferation: synergistic interaction between serotonin and low density lipoproteins.

Koba S, Pakala R, Watanabe T, Katagiri T, Benedict CR.

J Am Coll Cardiol. 1999 Nov 1;34(5):1644-51.

36.

Endothelial cells regulate the proliferation of monocytes in vitro.

Pakala R, Benedict CR.

Atherosclerosis. 1999 Nov 1;147(1):25-32.

PMID:
10525121
37.

Eicosapentaenoic acid and docosahexaenoic acid block serotonin-induced smooth muscle cell proliferation.

Pakala R, Pakala R, Sheng WL, Benedict CR.

Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2316-22.

PMID:
10521359
38.

Serotonin fails to induce proliferation of endothelial cells preloaded with eicosapentaenoic acid and docosahexaenoic acid.

Pakala R, Pakala R, Sheng WL, Benedict CR.

Atherosclerosis. 1999 Jul;145(1):137-46.

PMID:
10428304
39.

Thromboxane A2 fails to induce proliferation of smooth muscle cells enriched with eicosapentaenoic acid and docosahexaenoic acid.

Pakala R, Pakala R, Benedict CR.

Prostaglandins Leukot Essent Fatty Acids. 1999 Apr;60(4):275-81.

PMID:
10397410
40.

Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

McKelvie RS, Benedict CR, Yusuf S.

BMJ. 1999 May 22;318(7195):1400-2. Review. No abstract available.

41.

Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism.

Merten M, Pakala R, Thiagarajan P, Benedict CR.

Circulation. 1999 May 18;99(19):2577-82.

PMID:
10330391
42.

Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids.

Pakala R, Pakala R, Radcliffe JD, Benedict CR.

Prostaglandins Leukot Essent Fatty Acids. 1999 Feb;60(2):115-23. Erratum in: Prostaglandins Leukot Essent Fatty Acids 1999 Apr;60(4):283.

PMID:
10328332
43.
44.

Cardiolipin binding a light chain from lupus-prone mice.

Pereira B, Benedict CR, Le A, Shapiro SS, Thiagarajan P.

Biochemistry. 1998 Feb 3;37(5):1430-7.

PMID:
9477972
45.

Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model.

Thiagarajan P, Benedict CR.

Circulation. 1997 Oct 7;96(7):2339-47.

PMID:
9337209
46.

Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.

Pakala R, Willerson JT, Benedict CR.

Circulation. 1997 Oct 7;96(7):2280-6.

PMID:
9337201
47.

Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.

Patten RD, Kronenberg MW, Benedict CR, Udelson JE, Kinan D, Stewart D, Yusuf S, Smith JJ, Kilcoyne L, Dolan N, Edens TR, Metherall J, Konstam MA.

Am Heart J. 1997 Jul;134(1):37-43.

PMID:
9266781
48.

Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.

Weinberg EO, Lee MA, Weigner M, Lindpaintner K, Bishop SP, Benedict CR, Ho KK, Douglas PS, Chafizadeh E, Lorell BH.

Circulation. 1997 Mar 18;95(6):1592-600.

PMID:
9118530
49.

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group.

Rubenstein EB, Gralla RJ, Hainsworth JD, Hesketh PJ, Grote TH, Modiano MR, Khojasteh A, Kalman LA, Benedict CR, Hahne WF.

Cancer. 1997 Mar 15;79(6):1216-24.

PMID:
9070501
50.

Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.

Grote TH, Pineda LF, Figlin RA, Pendergrass KB, Hesketh PJ, Karlan BY, Reeves JA, Porter LL, Benedict CR, Hahne WF.

Cancer J Sci Am. 1997 Jan-Feb;3(1):45-51.

PMID:
9072308

Supplemental Content

Loading ...
Support Center